In some embodiments, the lipid-based drug delivery formulation or composition comprises a penetration enhancer (e.g., a low molecular weight alcohol (e.g., ethanol, oleyl alcohol), alkyl methanol sulphoxides, N-methyl-2-pyrrolidone, fatty amines (e.g., oleylamine), fatty acids (e.g., oleic acid, palmitoleic acid, linoleic acid, myristate acid), gluconic acid (the hexonic acid derived from glucose by oxidation of the aldehyde group at C-1 to a carboxyl group) and its derivatives, such as gluconolactone (especially, glucono-D-lactone, a chelating agent produced by the oxidation of glucose), azone and propylene glycol, singly or in combination)
[DOI] [PubMed] [Google Scholar] 106.Rochard P., Rodier A., Casas F., Cassar-Malek I., Marchal-Victorion S., Daury L., Wrutniak C., Cabello G
medical monitoring is advised
A prospective study of plasma total cysteine and risk of breast cancer